Early satiety and postprandial fullness in gastroparesis correlate with gastroparesis severity, gastric emptying, and water load testing
© 2016 John Wiley & Sons Ltd..
BACKGROUND: Early satiety (ES) and postprandial fullness (PPF) are often present in gastroparesis, but the importance of these symptoms in gastroparesis has not been well-described. The aims were: (i) Characterize ES and PPF in patients with gastroparesis. (ii) Assess relationships of ES and PPF with etiology of gastroparesis, quality of life, body weight, gastric emptying, and water load testing.
METHODS: Gastroparetic patients filled out questionnaires assessing symptoms (PAGI-SYM) and quality of life (PAGI-QOL, SF-36v2). Patients underwent gastric emptying scintigraphy and water load testing.
KEY RESULTS: 198 patients with gastroparesis (134 IG, 64 DG) were evaluated. Early satiety was severe or very severe in 50% of patients. Postprandial fullness was severe or very severe in 60% of patients. Severity scores for ES and PPF were similar between idiopathic and diabetic gastroparesis. Increasing severity of ES and PPF were associated with other gastroparesis symptoms including nausea/vomiting, satiety/early fullness, bloating, and upper abdominal pain and GERD subscores. Increasing severity of ES and PPF were associated with increasing gastroparesis severity, decreased BMI, decreased quality of life from PAGI-QOL and SF-36 physical health. Increasing severity of ES and PPF were associated with increasing gastric retention of a solid meal and decreased volume during water load test.
CONCLUSIONS & INFERENCES: Early satiety and PPF are commonly severe symptoms in both diabetic and idiopathic gastroparesis. Early satiety and PPF severity are associated with other gastroparesis symptom severities, body weight, quality of life, gastric emptying, and water load testing. Thus, ES and PPF are important symptoms characterizing gastroparesis. ClinicalTrials.gov number: NCT NCT01696747.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
|---|---|
| Enthalten in: |
Neurogastroenterology and motility - 29(2017), 4 vom: 26. Apr. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Parkman, H P [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Diabetic gastroparesis |
|---|
| Anmerkungen: |
Date Completed 15.02.2018 Date Revised 13.11.2018 published: Print-Electronic ClinicalTrials.gov: NCT01696747 Citation Status MEDLINE |
|---|
| doi: |
10.1111/nmo.12981 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM265653053 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM265653053 | ||
| 003 | DE-627 | ||
| 005 | 20231224212745.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/nmo.12981 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0885.xml |
| 035 | |a (DE-627)NLM265653053 | ||
| 035 | |a (NLM)27781342 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Parkman, H P |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Early satiety and postprandial fullness in gastroparesis correlate with gastroparesis severity, gastric emptying, and water load testing |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 15.02.2018 | ||
| 500 | |a Date Revised 13.11.2018 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ClinicalTrials.gov: NCT01696747 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2016 John Wiley & Sons Ltd. | ||
| 520 | |a BACKGROUND: Early satiety (ES) and postprandial fullness (PPF) are often present in gastroparesis, but the importance of these symptoms in gastroparesis has not been well-described. The aims were: (i) Characterize ES and PPF in patients with gastroparesis. (ii) Assess relationships of ES and PPF with etiology of gastroparesis, quality of life, body weight, gastric emptying, and water load testing | ||
| 520 | |a METHODS: Gastroparetic patients filled out questionnaires assessing symptoms (PAGI-SYM) and quality of life (PAGI-QOL, SF-36v2). Patients underwent gastric emptying scintigraphy and water load testing | ||
| 520 | |a KEY RESULTS: 198 patients with gastroparesis (134 IG, 64 DG) were evaluated. Early satiety was severe or very severe in 50% of patients. Postprandial fullness was severe or very severe in 60% of patients. Severity scores for ES and PPF were similar between idiopathic and diabetic gastroparesis. Increasing severity of ES and PPF were associated with other gastroparesis symptoms including nausea/vomiting, satiety/early fullness, bloating, and upper abdominal pain and GERD subscores. Increasing severity of ES and PPF were associated with increasing gastroparesis severity, decreased BMI, decreased quality of life from PAGI-QOL and SF-36 physical health. Increasing severity of ES and PPF were associated with increasing gastric retention of a solid meal and decreased volume during water load test | ||
| 520 | |a CONCLUSIONS & INFERENCES: Early satiety and PPF are commonly severe symptoms in both diabetic and idiopathic gastroparesis. Early satiety and PPF severity are associated with other gastroparesis symptom severities, body weight, quality of life, gastric emptying, and water load testing. Thus, ES and PPF are important symptoms characterizing gastroparesis. ClinicalTrials.gov number: NCT NCT01696747 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Observational Study | |
| 650 | 4 | |a diabetic gastroparesis | |
| 650 | 4 | |a early satiety | |
| 650 | 4 | |a gastric emptying | |
| 650 | 4 | |a gastroparesis | |
| 700 | 1 | |a Hallinan, E K |e verfasserin |4 aut | |
| 700 | 1 | |a Hasler, W L |e verfasserin |4 aut | |
| 700 | 1 | |a Farrugia, G |e verfasserin |4 aut | |
| 700 | 1 | |a Koch, K L |e verfasserin |4 aut | |
| 700 | 1 | |a Nguyen, L |e verfasserin |4 aut | |
| 700 | 1 | |a Snape, W J |e verfasserin |4 aut | |
| 700 | 1 | |a Abell, T L |e verfasserin |4 aut | |
| 700 | 1 | |a McCallum, R W |e verfasserin |4 aut | |
| 700 | 1 | |a Sarosiek, I |e verfasserin |4 aut | |
| 700 | 1 | |a Pasricha, P J |e verfasserin |4 aut | |
| 700 | 1 | |a Clarke, J |e verfasserin |4 aut | |
| 700 | 1 | |a Miriel, L |e verfasserin |4 aut | |
| 700 | 1 | |a Tonascia, J |e verfasserin |4 aut | |
| 700 | 1 | |a Hamilton, F |e verfasserin |4 aut | |
| 700 | 0 | |a NIDDK Gastroparesis Clinical Research Consortium (GpCRC) |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Neurogastroenterology and motility |d 1994 |g 29(2017), 4 vom: 26. Apr. |w (DE-627)NLM075187337 |x 1365-2982 |7 nnns |
| 773 | 1 | 8 | |g volume:29 |g year:2017 |g number:4 |g day:26 |g month:04 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/nmo.12981 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 29 |j 2017 |e 4 |b 26 |c 04 | ||